High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis

References

• Tsokos, G. C.; Lo, M. S.; Reis, P. C.; Sullivan, K. E. New Insights into the Immunopathogenesis of Systemic Lupus Erythematosus. Nat. Rev. Rheumatol. 2016, 12, 716.
   PubMed Web of Science ®Google Scholar
• Yu, F.; Haas, M.; Glassock, R.; Zhao, M.-H. Redefining Lupus Nephritis: Clinical Implications of Pathophysiologic Subtypes. Nat. Rev. Nephrol. 2017, 13(8), 483. DOI: 10.1038/nrneph.2017.85.
   PubMed Web of Science ®Google Scholar
• Qi, S.; Chen, Q.; Xu, D.; Xie, N.; Dai, Y. Clinical Application of Protein Biomarkers in Lupus Erythematosus and Lupus Nephritis. Lupus. 2018, 0961203318773643.
   Web of Science ®Google Scholar
• Yaniv, G.; Twig, G.; Shor, D. B.-A.; Furer, A.; Sherer, Y.; Mozes, O.;; et al. A Volcanic Explosion of Autoantibodies in Systemic Lupus Erythematosus: A Diversity of 180 Different Antibodies Found in SLE Patients. Autoimmunity Rev. 2017, 13, 75–79. DOI: 10.1016/j.autrev.2014.10.003.
   Google Scholar
• Pisetsky, D. S.;. Anti-DNA antibodies – Quintessential Biomarkers of SLE. Nat. Rev. Rheumatol. 2016, 12(2), 102. DOI: 10.1038/nrrheum.2015.151.
   PubMed Web of Science ®Google Scholar
• Fabrizio, C.; Fulvia, C.; Carlo, P.; Laura, M.; Elisa, M.; Francesca, M.; Francesca Romana, S.; Simona, T.; Cristiano, A.; Guido, V.;; et al. Systemic Lupus Erythematosus with and without anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort. Mediators Inflammation. 2015, 2015, 1–6. DOI: 10.1155/2015/328078.
   Web of Science ®Google Scholar
• Perricone, C.; Ceccarelli, F.; Massaro, L.; Alessandri, C.; Spinelli, F.; Marocchi, E.;; et al. AB0555 Systemic Lupus Erythematosus with or without Anti-Dsdna Antibodies: Not so Different. Ann. Rheumatic Dis. 2015, 74, 1085.
   Web of Science ®Google Scholar
• Min, D.; Kim, S.; Park, S.; Seo, Y.; Kang, H.; Kim, W.;; et al. Anti-nucleosome Antibody: Significance in Lupus Patients Lacking Anti-double-stranded DNA Antibody. Clin. exp. rheumatol. 2002, 20, 13–18.
   PubMed Web of Science ®Google Scholar
• Misra, R.; Gupta, R. Biomarkers in Lupus Nephritis. Int. J. Rheumatic Dis. 2015, 18, 219–232.
   PubMed Web of Science ®Google Scholar
• Khoshmirsafa, M.; Kianmehr, N.; Falak, R.; Mowla, S. J.; Seif, F.; Mirzaei, B.;; et al. Elevated Expression of miR‐21 and miR‐155 in Peripheral Blood Mononuclear Cells as Potential Biomarkers for Lupus Nephritis. Int. J. Rheumatic Dis. 2019, 22, 458–467.
   PubMed Web of Science ®Google Scholar
• Rekvig, O.;. Anti‐dsDNA Antibodies as a Classification Criterion and a Diagnostic Marker for Systemic Lupus Erythematosus: Critical Remarks. Clin. Exp. Immunol. 2015, 179, 5–10.
   PubMed Web of Science ®Google Scholar
• Villalta, D.; Bizzaro, N.; Bassi, N.; Zen, M.; Gatto, M.; Ghirardello, A.;; et al. Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG anti-dsDNA Help to Identify Glomerulonephritis and Active Disease. PloS One. 2013, 8, e71458.
   PubMed Web of Science ®Google Scholar
• Yung, S.; Chan, T. M. Mechanisms of Kidney Injury in Lupus Nephritis–the Role of anti-dsDNA Antibodies. Front. Immunol. 2015, 6, 475.
   PubMed Web of Science ®Google Scholar
• Pravinsagar, P.; Im, S.-W.; Jang, Y.-J. Pathogenic Effect of a Cell-penetrating anti-dsDNA Autoantibody through P38 Signaling Pathway and Pro-inflammatory Cytokine Stimulation in Mesangial Cells. Anim. Cells Syst. 2018, 22, 45–53.
   Web of Science ®Google Scholar
• Turner-Stokes, T.; Wilson, H. R.; Morreale, M.; Nunes, A.; Cairns, T.; Cook, H. T.;; et al. Positive Antineutrophil Cytoplasmic Antibody Serology in Patients with Lupus Nephritis Is Associated with Distinct Histopathologic Features on Renal Biopsy. Kidney Int. 2017, 92, 1223–1231.
   PubMed Web of Science ®Google Scholar
• Wener, M. H.; Uwatoko, S.; Mannik, M. Antibodies to the Collagen‐like Region of C1q in Sera of Patients with Autoimmune Rheumatic Diseases. Arthritis Rheum. 1989, 32, 544–551.
   PubMed Web of Science ®Google Scholar
• Uwatoko, S.; Aotsuka, S.; Okawa, M.; Egusa, Y.; Yokohari, R.; Aizawa, C.;; et al. Characterization of C1q-binding IgG Complexes in Systemic Lupus Erythematosus. Clin. Immunol. Immunopathol. 1984, 30, 104–116.
   PubMedGoogle Scholar
• Pickering, M. C.; Botto, M. Are anti-C1q Antibodies Different from Other SLE Autoantibodies? Nat. Rev. Rheumatol. 2010, 6, 490–493.
   PubMed Web of Science ®Google Scholar
• Chi, S.; Yu, Y.; Shi, J.; Zhang, Y.; Yang, J.; Yang, L.;, et al. Antibodies against C1q are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis. Dis. Markers. 2015, 2015.
   PubMed Web of Science ®Google Scholar
• Fatemi, A.; Samadi, G.; Sayedbonakdar, Z.; Smiley, A. Anti-C1q Antibody in Patients with Lupus Nephritic Flare: 18-month Follow-up and a Nested Case-control Study. Mod. Rheumatol. 2016, 26, 233–239.
   PubMed Web of Science ®Google Scholar
• Bock, M.; Heijnen, I.; Trendelenburg, M. Anti-C1q Antibodies as a Follow-up Marker in SLE Patients. PLoS One. 2015, 10, e0123572.
   PubMedGoogle Scholar
• Katsumata, Y.; Miyake, K.; Kawaguchi, Y.; Okamoto, Y.; Kawamoto, M.; Gono, T.;; et al. Anti‐C1q Antibodies are Associated with Systemic Lupus Erythematosus Global Activity but Not Specifically with Nephritis: A Controlled Study of 126 Consecutive Patients. Arthritis Rheum. 2011, 63, 2436–2444.
   PubMed Web of Science ®Google Scholar
• Mahler, M.; Van Schaarenburg, R.; Trouw, L. Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences. Front. Immunol. 2013, 4, 117.
   PubMed Web of Science ®Google Scholar
• Birmingham, D. J.; Bitter, J. E.; Ndukwe, E. G.; Dials, S.; Gullo, T. R.; Conroy, S.;; et al. Relationship of Circulating anti-C3b and anti-C1q IgG to Lupus Nephritis and Its Flare. Clin. J. Am. Soc. Nephrol. 2016, 11, 47–53.
   PubMed Web of Science ®Google Scholar
• Marinozzi, M. C.; Roumenina, L. T.; Chauvet, S.; Hertig, A.; Bertrand, D.; Olagne, J.;; et al. Anti-factor B and anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-associated Membranoproliferative GN. J. Am. Soc. Nephrol. 2017, 28, 1603–1613.
   PubMed Web of Science ®Google Scholar
• Birmingham, D. J.; Merchant, M.; Waikar, S. S.; Nagaraja, H.; Klein, J. B.; Rovin, B. H. Biomarkers of Lupus Nephritis Histology and Flare: Deciphering the Relevant Amidst the Noise. Nephrol. Dialysis Transplant. 2017, 32, i71–i79.
   PubMed Web of Science ®Google Scholar
• Vasilev, V. V.; Noe, R.; Dragon-Durey, M.-A.; Chauvet, S.; Lazarov, V. J.; Deliyska, B. P.;, et al. Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis. J. Biol. Chem. 2015, 647008.
   Web of Science ®Google Scholar
• Thanei, S.; Vanhecke, D.; Trendelenburg, M. Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Activate the Complement System via Both the Classical and Lectin Pathways. Clin. Immunol. 2015, 160, 180–187.
   PubMed Web of Science ®Google Scholar
• Stojan, G.; Petri, M. Anti-C1q in Systemic Lupus Erythematosus. Lupus. 2016, 25, 873–877.
   PubMed Web of Science ®Google Scholar
• Bigler, C.; Hopfer, H.; Danner, D.; Schaller, M.; Mihatsch, M. J.; Trendelenburg, M. Anti-C1q Autoantibodies Do Not Correlate with the Occurrence or Severity of Experimental Lupus Nephritis. Nephrol. Dialysis Transplant. 2010, 26, 1220–1228.
   PubMed Web of Science ®Google Scholar
• Sinico, R. A.; Rimoldi, L.; Radice, A.; Bianchi, L.; Gallelli, B.; Moroni, G. Anti‐C1q Autoantibodies in Lupus Nephritis. Ann. N.Y. Acad. Sci. 2009, 1173, 47–51.
   PubMed Web of Science ®Google Scholar
• Potlukova, E.; Jiskra, J.; Limanova, Z.; Kralikova, P.; Smutek, D.; Mareckova, H.;; et al. Autoantibodies against Complement C1q Correlate with the Thyroid Function in Patients with Autoimmune Thyroid Disease. Clin. Exp. Immunol. 2008, 153, 96–101.
   PubMed Web of Science ®Google Scholar
• Garmendia, J.; Muñoz, L.; Zabaleta, M.; Tassinari, P.; Bianco, N. Anti-C1q Antibodies in Patients with Chronic Idiopathic Urticaria. J. Allergy Clin. Immunol. 2004, 113, S257.
   PubMedGoogle Scholar
• Buck, A.; Christensen, J.; McCarty, M. Hypocomplementemic Urticarial Vasculitis Syndrome: A Case Report and Literature Review. J. Clin. Aesthetic Dermatol. 2012, 5(36).
   PubMedGoogle Scholar
• Flierman, R.; Daha, M. R. Pathogenic Role of anti-C1q Autoantibodies in the Development of Lupus Nephritis – a Hypothesis. Mol. Immunol. 2007, 44, 133–138.
   PubMed Web of Science ®Google Scholar
• Beurskens, F. J.; Van Schaarenburg, R. A.; Trouw, L. A. C1q, Antibodies and anti-C1q Autoantibodies. Mol. Immunol. 2015, 68, 6–13.
   PubMed Web of Science ®Google Scholar
• Krishnan, M. R.; Wang, C.; Marion, T. N. Anti-DNA Autoantibodies Initiate Experimental Lupus Nephritis by Binding Directly to the Glomerular Basement Membrane in Mice. Kidney Int. 2012, 82, 184–192.
   PubMed Web of Science ®Google Scholar
• Mannik, M.; Merrill, C. E.; Stamps, L. D.; Wener, M. H. Multiple Autoantibodies Form the Glomerular Immune Deposits in Patients with Systemic Lupus Erythematosus. J. Rheumatol. 2003, 30, 1495–1504.
   PubMed Web of Science ®Google Scholar
• Khoshmirsafa, M.; Seif, F.; Bagheri, N.; Beshkar, P.; Mousavi, M.; Shirzad, H. Correlation of Interleukin 6 and Transforming Growth Factor β1 with Peripheral Blood Regulatory T Cells in Rheumatoid Arthritis Patients: A Potential Biomarker. Cent. Eur. J. Immunol. 2018, 43, 281.
   PubMed Web of Science ®Google Scholar
• Ahn, S. S.; Yoo, B. W.; Song, J. J.; Park, Y. B.; Lee, S. K.; Lee, S. W. Anti‐Sm Is Associated with the Early Poor Outcome of Lupus Nephritis. Int. J. Rheumatic Dis. 2016, 19, 897–902.
   PubMed Web of Science ®Google Scholar
• Ishizaki, J.; Saito, K.; Nawata, M.; Mizuno, Y.; Tokunaga, M.; Sawamukai, N.;; et al. Low Complements and High Titre of anti-Sm Antibody as Predictors of Histopathologically Proven Silent Lupus Nephritis without Abnormal Urinalysis in Patients with Systemic Lupus Erythematosus. Rheumatology. 2014, 54, 405–412.
   PubMed Web of Science ®Google Scholar
• Kianmehr, N.; Khoshmirsafa, M.; Shekarabi, M.; Falak, R.; Seif, F.; Haghighi, A.;, et al., The Concurrent Anti-C1q and Anti-dsDNA but Not Anti-C3b Antibodies as Potent Biomarkers for Lupus Nephritis Prediction, 2020.
   Google Scholar